[Re: "Usefulness of p53 in the clinical management of bladder tumors", by S. Bernardini, E. Chabannes, H. Bittard. Prog. Urol., (2001), 11, 201-208].
Pfister
C
C
D006801:Humans; D009154:Mutation; D011379:Prognosis; D016159:Tumor Suppressor Protein p53 / Q000032:analysis* / Q000235:genetics; D001749:Urinary Bladder Neoplasms / Q000737:chemistry* / Q000235:genetics / Q000628:therapy
D016159:Tumor Suppressor Protein p53
Re: "Utilité du p53 dans la prise en charge clinique des tumeurs vésicales" par S. Bernardini, E. Chabannes, H. Bittard. Prog. Urol., (2001), 11, 201-208.